ArticleAnnals of medicine and surgery (2012)2025
The chicken chorioallantoic membrane model for human surgeries and implants.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fertilized chick egg, particularly its chorioallantoic membrane (CAM), has emerged as a valuable model in biomedical research due to its extensive applications in vascular studies, cancer investigations, surgical advancements including neurological, gynecological, urological, and retinal procedures, drug evaluation, and implant assessments. This review provides an in-depth examination of the chicken genome, structural composition of CAM, developmental progression, vascularization patterns, and cellular regulatory mechanisms. Furthermore, it underscores the CAM's significance in assessing therapeutic kinetics, biocompatibility, biodistribution, and drug effectiveness. A particular focus is placed on its role in analyzing vascular-disrupting agents (VDAs) for cancer treatment, alongside the incorporation of advanced imaging technologies such as photodynamic therapy, radiotherapy, positron emission tomography (PET)/computed tomography (CT) imaging, ultrasound techniques, and AI-driven detection methods for real-time vascular monitoring. By evaluating its advantages, limitations, and applications, this study establishes that CAM is a crucial alternative model for biomedical research, facilitating enhanced experimental design and methodological refinement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.